Publication | Closed Access

Pegylated liposomal doxorubicin (Lipo-Dox®) for platinum-resistant or refractory epithelial ovarian carcinoma: A Taiwanese gynecologic oncology group study with long-term follow-up

Long-term Follow-upMedicineGynecologyLiposomal DoxorubicinTumor TargetingCancer TreatmentOncologyRadiation OncologyGynecology OncologyOvarian Cancer